SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about certificate

12 Apr 2023 Evaluate

Pursuant to the requirement of Regulation of 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has confirmed that all activities, for financial year ended March 31, 2023, in relation to share transfer facility are maintained by Abhipra Capital (Registrar and Share Transfer Agent of the Company which is registered with the SEBI). Copy of Certificate issued by Abhipra Capital is enclosed.

The above information is a part of company’s filings submitted to BSE.


Orchid Pharma Share Price

564.10 -3.40 (-0.60%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×